Eric L. Snyder

2005 Washington University, Saint Louis, St. Louis, MO 
"Eric Snyder"
Mean distance: (not calculated yet)


Sign in to add mentor
Jeffrey Milbrandt grad student 2005 Washington University
 (Restoration of p53 tumor suppressor function in cancer cells by in vivo TAT -peptide transduction.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ghazi PC, O'Toole KT, Srinivas Boggaram S, et al. (2024) Inhibition of ULK1/2 and KRAS controls tumor growth in preclinical models of lung cancer. Biorxiv : the Preprint Server For Biology
Gillis K, Orellana WA, Wilson E, et al. (2023) FoxA1/2-dependent epigenomic reprogramming drives lineage switching in lung adenocarcinoma. Biorxiv : the Preprint Server For Biology
Kong R, Patel AS, Sato T, et al. (2022) Transcriptional Circuitry of NKX2-1 and SOX1 Defines an Unrecognized Lineage Subtype of Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine
Orstad G, Fort G, Parnell TJ, et al. (2022) FoxA1 and FoxA2 control growth and cellular identity in NKX2-1-positive lung adenocarcinoma. Developmental Cell
Ingram K, Samson SC, Zewdu R, et al. (2021) NKX2-1 controls lung cancer progression by inducing DUSP6 to dampen ERK activity. Oncogene
Zewdu R, Mehrabad EM, Ingram K, et al. (2021) An NKX2-1/ERK/WNT feedback loop modulates gastric identity and response to targeted therapy in lung adenocarcinoma. Elife. 10
Camolotto SA, Belova VK, Torre-Healy L, et al. (2020) Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4α and SIX1/4. Gut
Mollaoglu G, Jones A, Wait S, et al. (2020) Abstract B72: Lineage specifiers SOX2 and NKX2-1 inversely regulate tumor cell fate and neutrophil recruitment in lung cancer Cancer Immunology Research. 8
Kinsey CG, Camolotto SA, Boespflug AM, et al. (2019) Protective autophagy elicited by RAF→MEK→ERK inhibition suggests a treatment strategy for RAS-driven cancers. Nature Medicine
Camolotto SA, Torre-Healy L, Belova V, et al. (2019) Abstract C38: HNF4a regulates progression and molecular subtype of pancreatic ductal adenocarcinoma Cancer Research. 79
See more...